{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:55:53Z","timestamp":1755222953998,"version":"3.43.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The purpose of this exploratory study was to investigate the association between red blood cell count (RBC) and diabetic retinopathy (DR) and to develop a preliminary risk assessment framework.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 413 individuals diagnosed with type 2 diabetes mellitus (T2DM) at Suqian First Hospital\u2019s Endocrinology Department were included in this study. These participants were divided into training and validation groups in a 7:3 ratio, consisting of 289 and 124 patients respectively. In the training cohort, potential predictive variables were determined through both univariate and multivariate analyses utilizing forward-backward stepwise selection. Only variables with p &amp;lt; 0.05 were included in the nomogram, which encompassed demographic information, clinical laboratory results, and diabetes-associated complications. The performance of the model was evaluated in both groups using receiver operating characteristic (ROC) curve analysis, the Hosmer-Lemeshow test for calibration, and decision curve analysis (DCA) to determine clinical utility.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Out of 20 clinical variables examined, five were chosen to develop the nomogram: RBC, serum creatinine (SCR), diabetes duration, diabetic peripheral neuropathy (DPN), and diabetic kidney disease (DKD). The ROC analysis revealed that the area under the curve (AUC) for the training cohort was 0.765 (95% CI 0.709-0.821) and for the validation cohort was 0.707 (95% CI 0.616-0.798). Results from the Hosmer-Lemeshow test were p = 0.233 and p = 0.579, indicating a good fit. The nomogram demonstrated excellent predictive accuracy and provides a quantitative tool for assessing the risk of DR in individuals with T2DM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our findings suggest an inverse association between RBC levels and DR risk. The exploratory model incorporating RBC provides an initial framework for evaluating DR risk in patients with T2DM. Further validation in prospective cohorts is needed to refine this framework before considering clinical applications.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1571192","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T09:31:45Z","timestamp":1754904705000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Red blood cell count and its inverse association with diabetic retinopathy: Exploratory development of a risk assessment model in a retrospective cohort"],"prefix":"10.3389","volume":"16","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","first-page":"l5003","DOI":"10.1136\/bmj.l5003","article-title":"Trends in incidence of total or type 2 diabetes: systematic review","volume":"366","author":"Magliano","year":"2019","journal-title":"BMJ"},{"key":"B3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pcd.2020.01.003","article-title":"Prevalence of type 2 diabetes in Middle-East: Systematic review& meta-analysis","volume":"14","author":"Kalan Farmanfarma","year":"2020","journal-title":"Prim Care Diabetes"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.1887","article-title":"Global prevalence of diabetic retinopathy in pediatric type 2 diabetes: A systematic review and meta-analysis","volume":"6","author":"Cioana","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30128-1","article-title":"Incidence and progression of diabetic retinopathy: a systematic review","volume":"7","author":"Sabanayagam","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13480","article-title":"Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy","volume":"12","author":"Lin","year":"2021","journal-title":"J Diabetes Investig"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016510","article-title":"Platelet distribution width, platelet count, and plateletcrit in diabetic retinopathy: A systematic review and meta-analysis of PRISMA guidelines","volume":"98","author":"Ji","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037265","article-title":"Red blood cells as biomarkers and mediators in complications of diabetes mellitus: A review","volume":"103","author":"Obeagu","year":"2024","journal-title":"Med (Baltimore)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S43211","article-title":"Red blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus","volume":"9","author":"Wang","year":"2013","journal-title":"Vasc Health Risk Manage"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12649","article-title":"Altered red blood cell deformability-A novel hypothesis for retinal microangiopathy in diabetic retinopathy","volume":"27","author":"Tan","year":"2020","journal-title":"Microcirculation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017693","article-title":"Relationship between anemia, serum bilirubin concentrations, and diabetic retinopathy in individuals with type 2 diabetes","volume":"98","author":"Chung","year":"2019","journal-title":"Med (Baltimore)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"6653969","DOI":"10.1155\/2021\/6653969","article-title":"Association between red blood cell distribution width and diabetic retinopathy: A 5-year retrospective case-control study","volume":"2021","author":"Ma","year":"2021","journal-title":"J Ophthalmol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01582","article-title":"The effects of type 2 diabetes mellitus on organ metabolism and the immune system","volume":"11","author":"Daryabor","year":"2020","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1132036","article-title":"Development and validation of a diabetic retinopathy risk prediction model for middle-aged patients with type 2 diabetes mellitus","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00592-022-01973-1","article-title":"Development and validation of a model that predicts the risk of diabetic retinopathy in type 2 diabetes mellitus patients","volume":"60","author":"Yang","year":"2023","journal-title":"Acta Diabetol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"101578","DOI":"10.1016\/j.eclinm.2022.101578","article-title":"Development and validation of predictive risk models for sight threatening diabetic retinopathy in patients with type 2 diabetes to be applied as triage tools in resource limited settings","volume":"51","author":"Nugawela","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2024.07.004","article-title":"Plasma metabolomics identifies key metabolites and improves prediction of diabetic retinopathy: development and validation across multinational cohorts","volume":"131","author":"Yang","year":"2024","journal-title":"Ophthalmology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-022-05854-9","article-title":"Development and validation of medical record-based logistic regression and machine learning models to diagnose diabetic retinopathy","volume":"261","author":"Li","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B20","article-title":"Construction and clinical validation of a nomogram-based predictive model for diabetic retinopathy in type 2 diabetes","volume":"15","author":"Liu","year":"2023","journal-title":"Am J Transl Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4103\/jpbs.jpbs_138_22","article-title":"Correlation between diabetic retinopathy and diabetic peripheral neuropathy in patients with type II diabetes mellitus","volume":"14","author":"Hafeez","year":"2022","journal-title":"J Pharm Bioallied Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1484197","article-title":"Factors related to type 2 diabetic retinopathy and their clinical application value","volume":"15","author":"Lian","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1237_21","article-title":"Clinical correlation of diabetic retinopathy with nephropathy and neuropathy","volume":"69","author":"Saini","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1215292","article-title":"Ferroptosis: new insight into the mechanisms of diabetic nephropathy and retinopathy","volume":"14","author":"Li","year":"2023","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1571192\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T09:31:46Z","timestamp":1754904706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1571192\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":24,"alternative-id":["10.3389\/fendo.2025.1571192"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1571192","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"article-number":"1571192"}}